Allogeneic FE002-CART chondroprogenitor spheroids

Intervention1 paper2 findings

Cells1

Outcomes

2

Cellular viability

downin human cells1Very low certainty

1 study

Allogeneic FE002-CART chondroprogenitor spheroids protect against cellular viability in human cells.
Cellssevere inflammatory stress and 100% OA patient synovial fluid
Engineering Allogeneic FE002-Cart Chondroprogenitor Spheroids for Large Knee Chondral Defects: Investigating Microenvironmental Cues for Functional Control, GMP Formulation, and Logistical Viability · Pharmaceutics · 20 Aug 2026

Glycosaminoglycan

upin human cells1Very low certainty

1 study

Allogeneic FE002-CART chondroprogenitor spheroids increase glycosaminoglycan in human cells (10-fold).
Cellscompared to traditional matrix-seeded (MACI) platforms
Engineering Allogeneic FE002-Cart Chondroprogenitor Spheroids for Large Knee Chondral Defects: Investigating Microenvironmental Cues for Functional Control, GMP Formulation, and Logistical Viability · Pharmaceutics · 20 Aug 2026

Glycosaminoglycan →

Latest

1

PharmaceuticsCells27 Aug

Engineering Allogeneic FE002-Cart Chondroprogenitor Spheroids for Large Knee Chondral Defects: Investigating Microenvironmental Cues for Functional Control, GMP Formulation, and Logistical Viability